Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |